The Journal of Urology
Volume 179, Issue 2 , Pages 491-495 , February 2008

Florida Bladder Cancer Trends 1981 to 2004: Minimal Progress in Decreasing Advanced Disease

Received 26 June 2007

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106
  2. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666
  3. Nieder AM, John S, Messina CR, Granek IA, Adler HL. Are patients aware of the association between smoking and bladder cancer?. J Urol. 2006;176:2405
  4. Mansson A, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer—influence of psychosocial parameters and level of health-care provision. Scand J Urol Nephrol. 1993;27:363
  5. Mommsen S, Aagaard J, Sell A. Presenting symptoms, treatment delay and survival in bladder cancer. Scand J Urol Nephrol. 1983;17:163
  6. Araki M, Nieder AM, Manoharan M, Yang Y, Soloway MS. Lack of progress in early diagnosis of bladder cancer. Urology. 2007;69:270
  7. Hankey BF, Feuer EJ, Clegg LX, Hayes RB, Legler JM, Prorok PC, et al. Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91:1017
  8. Jhaveri FM, Klein EA, Kupelian PA, Zippe C, Levin HS. Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration. J Clin Oncol. 1999;17:3167
  9. Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;164:1768
  10. Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, et al. A side by side comparison of cytology and biomarkers for bladder cancer detection. J Urol. 2004;172:1123
  11. Toma MI, Friedrich MG, Hautmann SH, Jakel KT, Erbersdobler A, Hellstern A, et al. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol. 2004;22:145
  12. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol. 2004;21:392
  13. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control. 2002;13:83
  14. Burch JD, Rohan TE, Howe GR, Risch HA, Hill GB, Steele R, et al. Risk of bladder cancer by source and type of tobacco exposure: a case-control study. Int J Cancer. 1989;44:622
  15. Chacko JA, Heiner JG, Siu W, Macy M, Terris MK. Association between marijuana use and transitional cell carcinoma. Urology. 2006;67:100
  16. Nieder AM, Lipke MC, Madjar S. Transitional cell carcinoma associated with marijuana: case report and review of the literature. Urology. 2006;67:200
  17. Lotan Y, Svatek RS, Sagalowsky AI. Should we screen for bladder cancer in a high-risk population? (A cost per life-year saved analysis). Cancer. 2006;107:982
  18. Breslow RA, Sorkin JD, Frey CM, Kessler LG. Americans’ knowledge of cancer risk and survival. Prev Med. 1997;26:170
  19. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002;347:1087

 Study received University of Miami institutional review board approval.

 Supported by a Team Science Award from the James and Esther King Biomedical Research Program, Florida Department of Health, and Centers for Disease Control and Prevention.

PII: S0022-5347(07)02584-0

doi: 10.1016/j.juro.2007.09.082

The Journal of Urology
Volume 179, Issue 2 , Pages 491-495 , February 2008

Article Tools

* Image Usage & Resolution